SEC Form 4 · accession 0001209191-15-069059
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W. Nall
Officer — CEO & President · Director
Period of report
Aug 31, 2015
Accepted (ET)
Sep 2, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.01 | Aug 31, 2015 | A | 150,000 | A | — | Aug 30, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (8/31/15) with the balance vesting in equal monthly installments thereafter until fully vested on August 31, 2019.